161 related articles for article (PubMed ID: 12615358)
1. Loricrin keratoderma: a novel disease entity characterized by nuclear accumulation of mutant loricrin.
Ishida-Yamamoto A
J Dermatol Sci; 2003 Feb; 31(1):3-8. PubMed ID: 12615358
[TBL] [Abstract][Full Text] [Related]
2. A novel c.545-546insG mutation in the loricrin gene correlates with a heterogeneous phenotype of loricrin keratoderma.
Song S; Shen C; Song G; Mao X; Yan G; Wang X; Yan M; Zhong N
Br J Dermatol; 2008 Sep; 159(3):714-9. PubMed ID: 18844868
[TBL] [Abstract][Full Text] [Related]
3. Abnormal cornified cell envelope formation in mutilating palmoplantar keratoderma unrelated to epidermal differentiation complex.
Akiyama M; Christiano AM; Yoneda K; Shimizu H
J Invest Dermatol; 1998 Jul; 111(1):133-8. PubMed ID: 9665400
[TBL] [Abstract][Full Text] [Related]
4. Loricrin mutation in Vohwinkel's keratoderma is unique to the variant with ichthyosis.
Korge BP; Ishida-Yamamoto A; Pünter C; Dopping-Hepenstal PJ; Iizuka H; Stephenson A; Eady RA; Munro CS
J Invest Dermatol; 1997 Oct; 109(4):604-10. PubMed ID: 9326398
[TBL] [Abstract][Full Text] [Related]
5. Loricrin gene mutation in a Japanese patient of Vohwinkel's syndrome.
Takahashi H; Ishida-Yamamoto A; Kishi A; Ohara K; Iizuka H
J Dermatol Sci; 1999 Jan; 19(1):44-7. PubMed ID: 9890374
[TBL] [Abstract][Full Text] [Related]
6. Mutant loricrin is not crosslinked into the cornified cell envelope but is translocated into the nucleus in loricrin keratoderma.
Ishida-Yamamoto A; Kato H; Kiyama H; Armstrong DK; Munro CS; Eady RA; Nakamura S; Kinouchi M; Takahashi H; Iizuka H
J Invest Dermatol; 2000 Dec; 115(6):1088-94. PubMed ID: 11121146
[TBL] [Abstract][Full Text] [Related]
7. Collodion baby and loricrin keratoderma: a case report and mutation analysis.
Yeh JM; Yang MH; Chao SC
Clin Exp Dermatol; 2013 Mar; 38(2):147-50. PubMed ID: 22831754
[TBL] [Abstract][Full Text] [Related]
8. Loricrin keratoderma: a cause of congenital ichthyosiform erythroderma and collodion baby.
Matsumoto K; Muto M; Seki S; Saida T; Horiuchi N; Takahashi H; Ishida-Yamamoto A; Iizuka H
Br J Dermatol; 2001 Oct; 145(4):657-60. PubMed ID: 11703298
[TBL] [Abstract][Full Text] [Related]
9. A novel insertional mutation in loricrin in Vohwinkel's Keratoderma.
Armstrong DK; McKenna KE; Hughes AE
J Invest Dermatol; 1998 Oct; 111(4):702-4. PubMed ID: 9764857
[TBL] [Abstract][Full Text] [Related]
10. A molecular defect in loricrin, the major component of the cornified cell envelope, underlies Vohwinkel's syndrome.
Maestrini E; Monaco AP; McGrath JA; Ishida-Yamamoto A; Camisa C; Hovnanian A; Weeks DE; Lathrop M; Uitto J; Christiano AM
Nat Genet; 1996 May; 13(1):70-7. PubMed ID: 8673107
[TBL] [Abstract][Full Text] [Related]
11. A recurrent mutation in the loricrin gene underlies the ichthyotic variant of Vohwinkel syndrome.
O'Driscoll J; Muston GC; McGrath JA; Lam HM; Ashworth J; Christiano AM
Clin Exp Dermatol; 2002 May; 27(3):243-6. PubMed ID: 12072018
[TBL] [Abstract][Full Text] [Related]
12. Towards characterization of palmoplantar keratoderma caused by gain-of-function mutation in loricrin: analysis of a family and review of the literature.
Gedicke MM; Traupe H; Fischer B; Tinschert S; Hennies HC
Br J Dermatol; 2006 Jan; 154(1):167-71. PubMed ID: 16403113
[TBL] [Abstract][Full Text] [Related]
13. Structural and functional consequences of loricrin mutations in human loricrin keratoderma (Vohwinkel syndrome with ichthyosis).
Schmuth M; Fluhr JW; Crumrine DC; Uchida Y; Hachem JP; Behne M; Moskowitz DG; Christiano AM; Feingold KR; Elias PM
J Invest Dermatol; 2004 Apr; 122(4):909-22. PubMed ID: 15102081
[TBL] [Abstract][Full Text] [Related]
14. Transgenic mice expressing a mutant form of loricrin reveal the molecular basis of the skin diseases, Vohwinkel syndrome and progressive symmetric erythrokeratoderma.
Suga Y; Jarnik M; Attar PS; Longley MA; Bundman D; Steven AC; Koch PJ; Roop DR
J Cell Biol; 2000 Oct; 151(2):401-12. PubMed ID: 11038186
[TBL] [Abstract][Full Text] [Related]
15. Loricrin and human skin diseases: molecular basis of loricrin keratodermas.
Ishida-Yamamoto A; Takahashi H; Iizuka H
Histol Histopathol; 1998 Jul; 13(3):819-26. PubMed ID: 9690138
[TBL] [Abstract][Full Text] [Related]
16. Suppressing AP1 factor signaling in the suprabasal epidermis produces a keratoderma phenotype.
Rorke EA; Adhikary G; Young CA; Roop DR; Eckert RL
J Invest Dermatol; 2015 Jan; 135(1):170-180. PubMed ID: 25050598
[TBL] [Abstract][Full Text] [Related]
17. Activation of vascular endothelial growth factor receptor 2 in a cellular model of loricrin keratoderma.
Yoneda K; Demitsu T; Nakai K; Moriue T; Ogawa W; Igarashi J; Kosaka H; Kubota Y
J Biol Chem; 2010 May; 285(21):16184-94. PubMed ID: 20236940
[TBL] [Abstract][Full Text] [Related]
18. Variant of Vohwinkel's syndrome.
Ali MM; Upadya GM
Indian J Dermatol Venereol Leprol; 2006; 72(6):449-51. PubMed ID: 17179623
[TBL] [Abstract][Full Text] [Related]
19. Olmsted syndrome with squamous cell carcinoma of extremities and adenocarcinoma of the lung: failure to detect loricrin gene mutation.
Ogawa F; Udono M; Murota H; Shimizu K; Takahashi H; Ishida-Yamamoto A; Iizuka H; Katayama I
Eur J Dermatol; 2003; 13(6):524-8. PubMed ID: 14721769
[TBL] [Abstract][Full Text] [Related]
20. Translocation of profilaggrin N-terminal domain into keratinocyte nuclei with fragmented DNA in normal human skin and loricrin keratoderma.
Ishida-Yamamoto A; Takahashi H; Presland RB; Dale BA; Iizuka H
Lab Invest; 1998 Oct; 78(10):1245-53. PubMed ID: 9800950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
